Science
Hørsholm, Denmark -- Today, the Market Development Fund, announced that it will support Visiopharm’s validation of its novel solutions for cancer diagnostics at seven Danish Hospitals and three international Hospitals. Visiopharm’s...
Source: Dark Daily 7 May 2014 Prenatal testing, the most popular in China, is banned, affecting current projects at providers—another lesson for laboratories in how quickly things change Genetic testing has been halted in China. This...
Since the time I was a medical student, we were taught that for many of us, particularly those interested in pathology and laboratory medicine, that our jobs would be replaced by small computer chips and software applications that could...
Visit the PerkinElmer booth (#215) at the AAI Annual Meeting and learn about our full range of quantitative pathology imaging solutions. Label, image and count multiple phenotypes of immune cells in situ in FFPE tissue. Our technology platform...
In early 2009, I and many others were part of an organizing committee charged with putting together the program for CAP Futurescape and what later became known as Futurescape of Pathology. The idea for this meeting, was largely a CAP Foundation...
DALLAS, April 11, 2014 /PRNewswire/ -- The "Tissue Diagnostics Marketby Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate...
